A citation-based method for searching scientific literature

Susanne B Haga. Expert Rev Precis Med Drug Dev 2017
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Comparison of delivery strategies for pharmacogenetic testing services.
Susanne B Haga, Jivan Moaddeb. Pharmacogenet Genomics 2014
31
100




Adoption of pharmacogenomic testing by US physicians: results of a nationwide survey.
E J Stanek, C L Sanders, K A Johansen Taber, M Khalid, A Patel, R R Verbrugge, B C Agatep, R E Aubert, R S Epstein, F W Frueh. Clin Pharmacol Ther 2012
266
50

Genetic variation and pharmacogenomics: concepts, facts, and challenges.
Margret R Hoehe, Thomas Kroslak. Dialogues Clin Neurosci 2004
5
50

Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice.
Alessio Squassina, Mirko Manchia, Vangelis G Manolopoulos, Mehmet Artac, Christina Lappa-Manakou, Sophia Karkabouna, Konstantinos Mitropoulos, Maria Del Zompo, George P Patrinos. Pharmacogenomics 2010
81
50

The general public's understanding and perception of direct-to-consumer genetic test results.
J W Leighton, K Valverde, B A Bernhardt. Public Health Genomics 2012
84
50

Current ethical and legal issues in health-related direct-to-consumer genetic testing.
Emilia Niemiec, Louiza Kalokairinou, Heidi Carmen Howard. Per Med 2017
11
50

Exploring public genomics data for population pharmacogenomics.
Kleanthi Lakiotaki, Alexandros Kanterakis, Evgenia Kartsaki, Theodora Katsila, George P Patrinos, George Potamias. PLoS One 2017
22
50


Legislation of direct-to-consumer genetic testing in Europe: a fragmented regulatory landscape.
L Kalokairinou, H C Howard, S Slokenberga, E Fisher, M Flatscher-Thöni, M Hartlev, R van Hellemondt, J Juškevičius, J Kapelenska-Pregowska, P Kováč,[...]. J Community Genet 2018
28
50

The Human Genome Project: lessons from large-scale biology.
Francis S Collins, Michael Morgan, Aristides Patrinos. Science 2003
385
50

Pharmacogenomics guidelines: Current status and future development.
Chengxian Guo, Xiaoxue Xie, Jingao Li, Lihua Huang, Shaojun Chen, Xi Li, Xin Yi, Qin Wu, Guoping Yang, Honghao Zhou,[...]. Clin Exp Pharmacol Physiol 2019
7
50

Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing.
Megan A Allyse, David H Robinson, Matthew J Ferber, Richard R Sharp. Mayo Clin Proc 2018
55
50

Prescription medication changes following direct-to-consumer personal genomic testing: findings from the Impact of Personal Genomics (PGen) Study.
Deanna Alexis Carere, Tyler J VanderWeele, Jason L Vassy, Cathelijne H van der Wouden, J Scott Roberts, Peter Kraft, Robert C Green. Genet Med 2017
19
50

Publications from industry. Personal and corporate incentives.
Anthony J Kinney, Enno Krebbers, Steven J Vollmer. Plant Physiol 2004
1
100

Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
P H O'Donnell, N Wadhwa, K Danahey, B A Borden, S M Lee, J P Hall, C Klammer, S Hussain, M Siegler, M J Sorrentino,[...]. Clin Pharmacol Ther 2017
45
50

Updating the landscape of direct-to-consumer pharmacogenomic testing.
Kelly K Filipski, John D Murphy, Kathy J Helzlsouer. Pharmgenomics Pers Med 2017
9
50

Pharmacogenomics in the clinic.
Mary V Relling, William E Evans. Nature 2015
355
50

Direct-to-consumer genetic testing: a systematic review of european guidelines, recommendations, and position statements.
Muhammad Rafiq, Carolina Ianuale, Walter Ricciardi, Stefania Boccia. Genet Test Mol Biomarkers 2015
22
50


Pharmacogenetic testing through the direct-to-consumer genetic testing company 23andMe.
Mengfei Lu, Cathryn M Lewis, Matthew Traylor. BMC Med Genomics 2017
15
50

Ethical issues in consumer genome sequencing: Use of consumers' samples and data.
Emilia Niemiec, Heidi Carmen Howard. Appl Transl Genom 2016
25
50

Genetic variation in human drug-related genes.
Charlotta Pauline Irmgard Schärfe, Roman Tremmel, Matthias Schwab, Oliver Kohlbacher, Debora Susan Marks. Genome Med 2017
50
50



SUSHI: an exquisite recipe for fully documented, reproducible and reusable NGS data analysis.
Masaomi Hatakeyama, Lennart Opitz, Giancarlo Russo, Weihong Qi, Ralph Schlapbach, Hubert Rehrauer. BMC Bioinformatics 2016
35
50

The rise and fall and rise again of 23andMe.
Erika Check Hayden. Nature 2017
17
50

Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sources.
Tyler Shugg, Amy L Pasternak, Bianca London, Jasmine A Luzum. NPJ Genom Med 2020
3
50


The current landscape for direct-to-consumer genetic testing: legal, ethical, and policy issues.
Stuart Hogarth, Gail Javitt, David Melzer. Annu Rev Genomics Hum Genet 2008
153
50


Whole genome sequencing in pharmacogenomics.
Theodora Katsila, George P Patrinos. Front Pharmacol 2015
23
50

Clinical utility of microarrays: current status, existing challenges and future outlook.
Xinmin Li, Richard J Quigg, Jian Zhou, Weikuan Gu, P Nagesh Rao, Elaine F Reed. Curr Genomics 2008
36
50

Comprehension and Data-Sharing Behavior of Direct-To-Consumer Genetic Test Customers.
Scott P McGrath, Jason Coleman, Lotfollah Najjar, Ann Fruhling, Dhundy R Bastola. Public Health Genomics 2016
18
50


Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testing.
S L Van Driest, Y Shi, E A Bowton, J S Schildcrout, J F Peterson, J Pulley, J C Denny, D M Roden. Clin Pharmacol Ther 2014
164
50

Operational implementation of prospective genotyping for personalized medicine: the design of the Vanderbilt PREDICT project.
J M Pulley, J C Denny, J F Peterson, G R Bernard, C L Vnencak-Jones, A H Ramirez, J T Delaney, E Bowton, K Brothers, K Johnson,[...]. Clin Pharmacol Ther 2012
266
50

Characterizing treatment pathways at scale using the OHDSI network.
George Hripcsak, Patrick B Ryan, Jon D Duke, Nigam H Shah, Rae Woong Park, Vojtech Huser, Marc A Suchard, Martijn J Schuemie, Frank J DeFalco, Adler Perotte,[...]. Proc Natl Acad Sci U S A 2016
130
50

What is polypharmacy? A systematic review of definitions.
Nashwa Masnoon, Sepehr Shakib, Lisa Kalisch-Ellett, Gillian E Caughey. BMC Geriatr 2017
599
50

Lexicomp App Review.
Andres Elovic, Ali Pourmand. J Digit Imaging 2020
1
100

Insurance coverage policies for personalized medicine.
Andrew Hresko, Susanne B Haga. J Pers Med 2012
59
50

Clinical Relevance of CYP2D6 Polymorphisms in Patients of an Austrian Medical Practice: A Family Practice-Based Observational Study.
Gustav Kamenski, Seda Ayazseven, Anne Berndt, Waltraud Fink, Lukas Kamenski, Sonja Zehetmayer, Helene Pühringer. Drugs Real World Outcomes 2020
4
50


PGRNseq: a targeted capture sequencing panel for pharmacogenetic research and implementation.
Adam S Gordon, Robert S Fulton, Xiang Qin, Elaine R Mardis, Deborah A Nickerson, Steve Scherer. Pharmacogenet Genomics 2016
59
50

Potentially inappropriate medication use in elderly Japanese patients.
Manabu Akazawa, Hirohisa Imai, Ataru Igarashi, Kiichiro Tsutani. Am J Geriatr Pharmacother 2010
89
50

Implementation outcomes of Humanwide: integrated precision health in team-based family practice primary care.
Cati G Brown-Johnson, Nadia Safaeinili, Juliana Baratta, Latha Palaniappan, Megan Mahoney, Lisa G Rosas, Marcy Winget. BMC Fam Pract 2021
1
100

An overview of prevalence, determinants and health outcomes of polypharmacy.
Mina Khezrian, Chris J McNeil, Alison D Murray, Phyo K Myint. Ther Adv Drug Saf 2020
24
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.